CID 170647464

Dabogratinib

Structural Information

Molecular Formula
C25H24Cl2N6O3S
SMILES
C[C@H](C1=C(C=NC=C1Cl)Cl)OC2=CC3=C(C=C2)NN=C3C4=CN=C(C=C4)N5CC6(C5)CN(C6)S(=O)(=O)C
InChI
InChI=1S/C25H24Cl2N6O3S/c1-15(23-19(26)9-28-10-20(23)27)36-17-4-5-21-18(7-17)24(31-30-21)16-3-6-22(29-8-16)32-11-25(12-32)13-33(14-25)37(2,34)35/h3-10,15H,11-14H2,1-2H3,(H,30,31)/t15-/m1/s1
InChIKey
JOAFWIHZEBKYQK-OAHLLOKOSA-N
Compound name
5-[(1R)-1-(3,5-dichloropyridin-4-yl)ethoxy]-3-[6-(2-methylsulfonyl-2,6-diazaspiro[3.3]heptan-6-yl)pyridin-3-yl]-1H-indazole
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

14
Patents

558.10077 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 559.10805 202.6
[M+Na]+ 581.08999 209.7
[M-H]- 557.09349 207.0
[M+NH4]+ 576.13459 194.1
[M+K]+ 597.06393 208.1
[M+H-H2O]+ 541.09803 182.1
[M+HCOO]- 603.09897 198.6
[M+CH3COO]- 617.11462 206.9
[M+Na-2H]- 579.07544 201.8
[M]+ 558.10022 223.1
[M]- 558.10132 223.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe